| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/14/1998 | WO1998019685A1 Method of treating bronchitis with uridine triphosphates and related compounds |
| 05/13/1998 | EP0841318A2 Optical isomers of derivatives of campholenic aldehyde |
| 05/13/1998 | EP0840740A1 New inhibitors of platelet aggregation |
| 05/12/1998 | US5750724 Indolealkyl derivatives of benzodioxanmethylamine |
| 05/07/1998 | WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | WO1998018477A2 Pharmaceutical compositions containing lamivudine and zidovudine |
| 05/07/1998 | WO1998018438A1 Antiperspirant composition |
| 05/07/1998 | CA2270174A1 Pharmaceutical compositions containing lamivudine and zidovudine |
| 05/07/1998 | CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/06/1998 | EP0591452B1 Multiple emulsions and methods of preparation |
| 05/06/1998 | CN1181015A Reduction of infarct volume using citicoline |
| 05/06/1998 | CA2220273A1 Optical isomers of derivatives of campholenic aldehyde |
| 05/05/1998 | US5747646 Polyethylene-protein conjugates |
| 05/05/1998 | US5747522 Anticoagulants; antiinflammatory agents; antitumor agents |
| 05/05/1998 | US5747496 Inhibitors of platelet aggregation |
| 05/05/1998 | US5747462 Pharmaceutically active compounds and their use |
| 05/05/1998 | CA2078596C Dispersions |
| 04/30/1998 | WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | WO1998017673A1 Isosorbide aspirinate esters |
| 04/30/1998 | WO1998017261A1 Method for preparing a multi-particulate pharmaceutical form with controlled multi-sequential release |
| 04/30/1998 | WO1998017255A1 Preparation for the transport of an active substance across barriers |
| 04/30/1998 | CA2268670A1 Preparation for transporting active ingredients through barriers |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/29/1998 | EP0838522A2 Coccidiosis poultry vaccine |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0837669A1 Methods and compositions for use against dental calculus in domestic animals |
| 04/28/1998 | US5744500 Administering to treat brain ischemia or stroke |
| 04/28/1998 | US5744495 Immunomodulatory agents |
| 04/28/1998 | US5744470 Method for treating insomnia |
| 04/28/1998 | US5744146 High melting wax, acetylated monoglyceride, petrolatum and fatty alcohol |
| 04/23/1998 | WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | WO1998016233A1 Formulations containing phosphatidylethanolamine |
| 04/23/1998 | WO1998016232A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of vasomotor symptoms |
| 04/23/1998 | WO1998016216A1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 04/23/1998 | CA2268008A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/22/1998 | EP0836485A2 Cascade polymer complexes |
| 04/22/1998 | EP0836475A1 Controlled release formulations for poorly soluble drugs |
| 04/22/1998 | EP0703774B1 High foaming oral composition |
| 04/22/1998 | CN1179722A Combination therapy for HIV infection using HIV protease inhibitor indinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 04/21/1998 | US5741524 Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility |
| 04/21/1998 | US5741512 Pharmaceutical compositions comprising cyclosporins |
| 04/16/1998 | WO1998008488A3 Cold cream cosmetic composition |
| 04/15/1998 | EP0835663A2 Combined vaccines comprising Hepatitis B surface antigen and other antigens |
| 04/15/1998 | EP0835098A1 New, stable medicinal compositions for generating propellant-free aerosols |
| 04/15/1998 | EP0714388B1 Vasoconstrictive substituted aryloxyalkyl diamines |
| 04/15/1998 | CN1179097A Carrier particles for use in dry powder inhalers |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/14/1998 | US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/09/1998 | WO1998014447A1 Novel indole-2,3-dione-3-oxime derivatives |
| 04/08/1998 | EP0833604A1 Clear cosmetic stick composition |
| 04/08/1998 | EP0614351B1 Suspending agents for insoluble components of cleaning compositions formed by reacting alkyl ammonium salts with anionic surfactants |
| 04/08/1998 | CN1178461A Pharmaceutical compositions comprising monoamine oxidase B inhibitors |
| 04/07/1998 | US5736525 Used for treatemnt of acquired immuno deficiency syndrome with anti-aids drugs selected from 3'-azido-3'-deoxythymidine(azt), dideoxyinosine(ddi), or dideoxycytidine(ddc) |
| 04/02/1998 | WO1998013021A1 Preparation protecting skin from mechanical irritation |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2213257A1 Oligopeptide derivatives |
| 04/01/1998 | EP0832971A1 Adheson variants |
| 04/01/1998 | EP0831898A1 Modified meningococcal polysaccharide conjugate vaccines |
| 04/01/1998 | EP0831897A1 In ovo vaccination against coccidiosis |
| 04/01/1998 | EP0831847A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis |
| 04/01/1998 | EP0831841A1 Means for treating radiation injuries |
| 04/01/1998 | EP0831768A1 Topical vehicles containing solubilized and stabilized azelaic acid |
| 04/01/1998 | EP0831766A1 Sunscreen compositions |
| 04/01/1998 | EP0716599B1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-$g(b)-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
| 03/31/1998 | US5733937 Aminoethyloxybenzenealkylenephenols |
| 03/31/1998 | US5733934 Antiarrythmic and cardioprotective substituted indenoylguanidines |
| 03/31/1998 | US5733534 Antiperspirant stick compositions exhibiting improved wash-off performance |
| 03/31/1998 | CA2084869C Mouthwash compositions |
| 03/26/1998 | WO1998011778A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 03/26/1998 | WO1997034564A3 Treatment of chronic inflammatory intestinal diseases by a phyto-compound |
| 03/25/1998 | CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof |
| 03/25/1998 | CN1177303A Application of lysozyme dimer |
| 03/24/1998 | US5731441 Hydroxamic acid derivatives with tricyclic substitution |
| 03/24/1998 | US5731342 Benzothiophenes, formulations containing same, and methods |
| 03/24/1998 | US5731335 Nervous system disorders; stroke; antiischemic agents; cognition activators |
| 03/24/1998 | US5731000 Stabilized pharmaceutical composition containing bupropion |
| 03/24/1998 | US5730963 Cosmetic gel composition having reduced skin irritation |
| 03/18/1998 | EP0829263A1 Use of 8,9-dehydroestrone in estrogen therapy |
| 03/18/1998 | EP0828496A1 Use of alendronate for the prevention of osteoporosis |
| 03/18/1998 | EP0828494A1 Method for treating cognitive dysfunction |
| 03/18/1998 | EP0828485A1 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof |
| 03/18/1998 | EP0662004B1 Use of persistent free-radicals in magnetic resonance imaging |
| 03/18/1998 | CN1176646A CCK or gastrin modulating 5 -heterocyclic-1, 5-benzodiazepines |
| 03/17/1998 | US5728874 Anti-HIV achiral polyurea oligomers, a process for creating them, formulations using them, and their use in the treatment of AIDS |
| 03/17/1998 | US5728731 Administering a polyamide oligomer to a patient to treat a herpes viral infection |
| 03/17/1998 | US5728569 Inoculation of embryonated eggs, propagation, harvesting |
| 03/16/1998 | CA2215655A1 Use of 8,9-dehydroestrone as an estrogen with neutral effects on prolactin levels |
| 03/12/1998 | WO1998009599A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives |
| 03/12/1998 | CA2718347A1 Gene therapy for congestive heart failure |
| 03/11/1998 | EP0827514A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions |
| 03/11/1998 | EP0827404A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis |
| 03/11/1998 | EP0827391A1 Cosmetic composition including an acrylic anionic polymer and an oxyalkylene silicone |
| 03/11/1998 | EP0633879B1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders |
| 03/11/1998 | CN1175465A Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates |
| 03/11/1998 | CN1175411A Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs. |